Estudio presentado por el Dr. Gilles Montalescot en el último ACC.2013, realizado en San Francisco, Estados Unidos, los días 9, 10 y 11 de Marzo. Más presentaciones de este evento en www.solaci.org/es/coberturas.php
Nivolumab, a programmed death 1 (PD-1) checkpoint inhibitor, was associated with encouraging overall survival in uncontrolled studies involving previously treated patients with advanced renal-cell carcinoma. This randomized, open-label, phase 3 study compared nivolumab with everolimus in patients with renal-cell carcinoma who had received previous treatment.
Estudio presentado por el Dr. Gilles Montalescot en el último ACC.2013, realizado en San Francisco, Estados Unidos, los días 9, 10 y 11 de Marzo. Más presentaciones de este evento en www.solaci.org/es/coberturas.php
Nivolumab, a programmed death 1 (PD-1) checkpoint inhibitor, was associated with encouraging overall survival in uncontrolled studies involving previously treated patients with advanced renal-cell carcinoma. This randomized, open-label, phase 3 study compared nivolumab with everolimus in patients with renal-cell carcinoma who had received previous treatment.
Dr. mahajna muhammad MD
sackler faculty of medicine
Tel-Aviv Uni.
The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y12 receptor antagonist with established efficacy after an acute coronary syndrome, in this context.
Gouden eeuw college 3 vincent icke - huygensVeenMedia
Zonder Huygens geen Einstein
Vincent Icke
Historisch Nieuwsblad, 29-05-2015
De grootste schok die de wetenschap aan het begin van de zeventiende eeuw veroorzaakte was het besef dat het overgrote deel van ons Heelal buiten het bereik van onze zintuigen valt. We hebben instrumenten nodig, bijvoorbeeld telescopen en microscopen, maar ook die hebben beperkingen. Dus is er nooit zekerheid in de natuurkunde. Christiaan Huygens schreef daarover: Men zal hier een soort redeneringen zien die niet zo’n grote zekerheid bieden als de wiskunde[...] Toch is het mogelijk om op die manier een mate van waarschijnlijkheid te bereiken die bijna niet onderdoet voor absolute zekerheid. Zo is het gebleven sinds die zeventiende eeuw. Zie bijvoorbeeld Huygens’ verklaring van de waarnemingen van de planeet Saturnus, of Einsteins beschrijving van de structuur van ruimte en tijd. Supergeniaal werk, maar toch: als onze zintuigen ontoereikend zijn, zijn onze hersenen dan wel goed genoeg?
Vincent Icke
Vincent Icke (Utrecht, 1946) is hoogleraar Theoretische Astrofysica aan Universiteit Leiden en bijzonder hoogleraar Kosmologie aan de Universiteit van Amsterdam. Hij studeerde theoretische natuurkunde en sterrenkunde aan de Universiteit van Utrecht. In 1972 promoveerde hij te Leiden op het proefschrift Formation of Galaxies Inside Clusters. Hij deed postdoctoraal onderzoek aan de universiteiten van Sussex en Cambridge, en aan het California Institute of Technology. Na vijf jaar als staflid aan de Universiteit van Minnesota kwam hij naar Leiden. Zijn onderzoeksgebied omvat onder andere de oorsprong van structuren in het Heelal, stralings-hydrodynamica, en de relatie tussen de algemene relativiteitstheorie en de quantumveldentheorie.
Vincent Icke heeft zich vanaf het begin van zijn loopbaan ingezet om de natuurwetenschappen voor algemeen publiek toegankelijk te maken. Hij schrijft voor dag- en weekbladen, zoals NRC Handelsblad, NewScientist en Nederlands Tijdschrift voor Natuurkunde. Hij is regelmatig te gast op radio en televisie, waaronder NieuwsBV, Nieuwslicht en De Wereld Draait Door. Tot zijn talrijke publicaties behoren The force of symmetry (1999), Christiaan Huygens in de onvoltooid verleden toekomende tijd (2005), Niks relatief (2006), Dat kan ik me niet voorstellen (2009), De ruimte van Christiaan Huygens (2009), De principes van Huygens (2013) en Zwaartekracht bestaat niet (2014). Een aantal van zijn colleges en lezingen verschenen op cd en dvd: Christiaan Huygens, Kosmische Krachten, Grote Natuurkundige Theorieën, en Alles voor één meisje.
Vincent Icke is niet alleen astrofysicus maar ook beeldend kunstenaar. Uiteraard is zijn kunst soms geïnspireerd op de zichtbare schoonheid en de verborgen werking van de wonderen van het Heelal. Hij werkte mee aan de oprichting van de Faculteit der Kunsten aan Universiteit Leiden, en is lid van de Raad van Toezicht van de Gerrit Rietveld Academie.
Meer informatie over het academische werk van Vinc
Dr. mahajna muhammad MD
sackler faculty of medicine
Tel-Aviv Uni.
The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y12 receptor antagonist with established efficacy after an acute coronary syndrome, in this context.
Gouden eeuw college 3 vincent icke - huygensVeenMedia
Zonder Huygens geen Einstein
Vincent Icke
Historisch Nieuwsblad, 29-05-2015
De grootste schok die de wetenschap aan het begin van de zeventiende eeuw veroorzaakte was het besef dat het overgrote deel van ons Heelal buiten het bereik van onze zintuigen valt. We hebben instrumenten nodig, bijvoorbeeld telescopen en microscopen, maar ook die hebben beperkingen. Dus is er nooit zekerheid in de natuurkunde. Christiaan Huygens schreef daarover: Men zal hier een soort redeneringen zien die niet zo’n grote zekerheid bieden als de wiskunde[...] Toch is het mogelijk om op die manier een mate van waarschijnlijkheid te bereiken die bijna niet onderdoet voor absolute zekerheid. Zo is het gebleven sinds die zeventiende eeuw. Zie bijvoorbeeld Huygens’ verklaring van de waarnemingen van de planeet Saturnus, of Einsteins beschrijving van de structuur van ruimte en tijd. Supergeniaal werk, maar toch: als onze zintuigen ontoereikend zijn, zijn onze hersenen dan wel goed genoeg?
Vincent Icke
Vincent Icke (Utrecht, 1946) is hoogleraar Theoretische Astrofysica aan Universiteit Leiden en bijzonder hoogleraar Kosmologie aan de Universiteit van Amsterdam. Hij studeerde theoretische natuurkunde en sterrenkunde aan de Universiteit van Utrecht. In 1972 promoveerde hij te Leiden op het proefschrift Formation of Galaxies Inside Clusters. Hij deed postdoctoraal onderzoek aan de universiteiten van Sussex en Cambridge, en aan het California Institute of Technology. Na vijf jaar als staflid aan de Universiteit van Minnesota kwam hij naar Leiden. Zijn onderzoeksgebied omvat onder andere de oorsprong van structuren in het Heelal, stralings-hydrodynamica, en de relatie tussen de algemene relativiteitstheorie en de quantumveldentheorie.
Vincent Icke heeft zich vanaf het begin van zijn loopbaan ingezet om de natuurwetenschappen voor algemeen publiek toegankelijk te maken. Hij schrijft voor dag- en weekbladen, zoals NRC Handelsblad, NewScientist en Nederlands Tijdschrift voor Natuurkunde. Hij is regelmatig te gast op radio en televisie, waaronder NieuwsBV, Nieuwslicht en De Wereld Draait Door. Tot zijn talrijke publicaties behoren The force of symmetry (1999), Christiaan Huygens in de onvoltooid verleden toekomende tijd (2005), Niks relatief (2006), Dat kan ik me niet voorstellen (2009), De ruimte van Christiaan Huygens (2009), De principes van Huygens (2013) en Zwaartekracht bestaat niet (2014). Een aantal van zijn colleges en lezingen verschenen op cd en dvd: Christiaan Huygens, Kosmische Krachten, Grote Natuurkundige Theorieën, en Alles voor één meisje.
Vincent Icke is niet alleen astrofysicus maar ook beeldend kunstenaar. Uiteraard is zijn kunst soms geïnspireerd op de zichtbare schoonheid en de verborgen werking van de wonderen van het Heelal. Hij werkte mee aan de oprichting van de Faculteit der Kunsten aan Universiteit Leiden, en is lid van de Raad van Toezicht van de Gerrit Rietveld Academie.
Meer informatie over het academische werk van Vinc
Fidelização de Clientes na Distribuição Moderna- Solange AlbertoJornadasPublicidade
Intervenção do estudo de Solange Alberto nas VI Jornadas de Publicidade & Comunicação que decorreu na Escola Superior de Comunicação Social, no dia 23 de Outubro de 2014.
Slides para apresentação
Publicidade infantil: entenda quais são os perigos
As crianças são consideradas sensíveis e vulneráveis à publicidade, por isso a propaganda para esse público deve ser regulada cuidadosamente
Por ser um público extremamente sugestionável, persuadido com facilidade, as crianças são vistas pelas empresas como parte relevante do mercado. Para o Idec, tendo como base o artigo 37 do Código de Defesa do Consumidor, a publicidade direcionada ao público infantil é abusiva pois se aproveita da deficiência de julgamento da criança. O Conselho Federal de Psicologia afirma que “além da menor experiência de vida e de menor acúmulo de conhecimentos, a criança ainda não possui a sofisticação intelectual para abstrair as leis (físicas e sociais) que regem esse mundo, para avaliar criticamente os discursos que outros fazem a seu respeito”.
Segundo a advogada do Idec Mariana Ferraz, a criança é muito sensível às práticas de marketing. A problemática fica ainda maior quando a publicidade estimula padrões de consumo alimentares não saudáveis.
No caso do setor alimentício, muitas empresas lançam mão de práticas desleais, como a associação da alimentação a brinquedos, ou utilização de linguagem lúdica própria ao universo infantil em suas peças publicitárias. “A OMS (Organização Mundial da Saúde) já se pronunciou pela necessidade da regulação da publicidade de alimentos e, em 2012, a Opas (Organização Pan-Americana da Saúde) publicou recomendações http://www.idec.org.br/em-acao/em-foco/idec-cobra-do-governo-regulaco-da-publicidade-infantil para a regulação da publicidade de alimentos não-saudáveis direcionada às crianças. Resta que os governos adotem essas recomendações e implementem políticas para regrar a publicidade direcionada às crianças”, afirma a advogada.
Desde 2005 a OMS reconhece a comercialização de alimentos não saudáveis para a população infantil como um fator que contribui para o aumento dos níveis de obesidade e sobrepeso. Embora alguns acordos diretos com empresas do setor alimentício tenham sido fechados, o órgão tem ressaltado que cabe aos governos a responsabilidade de garantir a tomada de medidas efetivas, bem como o monitoramento dos acordos de restrição da publicidade de alimentos não saudáveis voltados às crianças.
“O Idec entende que toda publicidade que tem o público infantil como interlocutor desrespeita o princípio da identificação, pois a criança não tem condições de analisar criticamente o interesse mercadológico que existe por trás da informação direcionada a ela. Por ser hipervulnerável às práticas de marketing, esse público merece especial proteção”,
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Presented at AHA by: Faiez Zannad, M.D., Ph.D., John J.V. McMurray, M.D., Henry Krum, M.B., PhD., Dirk J. van Veldhuisen, M.D.,Ph.D., Karl Swedberg, M.D., Ph.D, Harry Shi, M.S., John Vincent, M.B., PhD., Stuart J Pocock, Ph.D. and Bertram Pitt, M.D. for the EMPHASIS-HF Study Group * Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure
Courtesy of http://www.cardiovascularbusiness.com
Talimogene laherparepvec (T-VEC, OncoVEX GM-CSF) phase 3 data in melanoma pre...Virotherapist
Phase 3 data from the OPTiM study in melanoma with talimogene laherparepvec presented as part of a talk on oncolytic immunotherapy at The Eighth International Conference on Oncolytic Virus Therapeutics, Oxford, UK,9-13 April 2014.
Similar to Estudio REMINDER: Administración precoz de eplerenona en pacientes con IAM sin insuficiencia cardiaca (20)
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Estudio REMINDER: Administración precoz de eplerenona en pacientes con IAM sin insuficiencia cardiaca
1. Early Eplerenone Treatment in Patients
with Acute ST-elevation Myocardial
Infarction without Heart Failure
REMINDER*
Gilles Montalescot, Bertram Pitt, Esteban Lopez de Sa, Christian W. Hamm,
Marcus Flather, Freek Verheugt, Harry Shi, Eva Turgonyi, Miguel Orri,
John Vincent and Faiez Zannad for the REMINDER Investigators
*A Double-Blind, Randomized, Placebo-Controlled Trial Evaluating The Safety And Efficacy Of
Early Treatment With Eplerenone In Patients With Acute Myocardial Infarction
ClinicalTrials.gov, NCT01176968
2. Study Design
Mean Follow-up 10.5 months
Randomization
25 mg
Eplerenone 25-50 mg qd*
(+ standard of care)
Placebo 25-50 mg qd*
(+ standard of care)
1 Day 2nd Day
25 mg
* Dosing based on serum potassium levels and eGFR levels; 88.6% finally received 50 mg in
the eplerenone group
3. Study Patients
INCLUSION
– Eligible subjects were identified for inclusion following emergency room
or ambulance evaluation and diagnosis of acute STEMI in the absence
of a diagnosis of HF
– Randomization had to take place as early as possible following
diagnosis and the first dose of study drug administered as early as
possible within 24 hours of the onset of symptoms of acute MI and
preferably within 12 hours.
KEY EXCLUSION CRITERIA
– Known ejection fraction < 40%, any previous history of heart failure
– Implanted cardioverter defibrillator
– Known renal insufficiency or eGFR ≤ 30 ml/min/1.73m2
– Uncontrolled hypotension (systolic blood pressure < 90 mmHg)
– Any other clinically significant coexisting condition
5. Primary Endpoint
PRIMARY ENDPOINT: Time to first occurrence of CV mortality, re-hospitalization or extended
initial hospital stay due to diagnosis of HF or sustained ventricular tachycardia or ventricular
fibrillation, as well as at 1 month post randomization: LVEF ≤ 40% or elevated BNP / NT-proBNP
Eplerenone vs Placebo:
HR [95% CI] = 0.581 [0.449, 0.753]
P = <0.0001
7. Conclusions
• This study shows that compared with placebo
the addition of eplerenone to standard therapy
within 24 hours of symptom onset improves the
outcome of patients presenting with acute
STEMI without evidence of HF or LVEF <40%.
• This is the first large study to demonstrate the
safety profile of eplerenone during early
administration (no prior potassium check, titrated
from 25 to 50 mg on day 2).